Katie Ewer | |
---|---|
Academic background | |
Education | PhD, Immunology, 2004, Open University |
Thesis | Relationships between tuberculosis exposure, ex vivo antigen-specific T cell responses, and delayed type hypersensitivity in point-source outbreaks. (2004) |
Academic work | |
Institutions | University of Oxford |
Katie Jane Ewer is a British immunologist and Professor of Vaccine Immunology at the University of Oxford's Jenner Institute. [1]
When she did not get into medical school, Ewer pursued a career in biomedical science and became interested in infectious diseases. [2] She was interested in a career in biology for she was "fascinated by seemingly endless processes that occur in our cells and organs every second of our lives without us knowing about it. [3] Ewer earned an undergraduate degree in biomedical science, which included a year of microbiology training. [4] She then began working as a biomedical scientist at the microbiology department of the John Radcliffe Hospital in 2000, [5] before pursuing a PhD on the immunology of tuberculosis (TB). [4] Ewer earned her PhD at the Open University as a result of her research with Ajit Lalvani on novel diagnostic tools using T cells for the diagnosis of tuberculosis infection. [5]
Upon earning her PhD, Ewer joined the UK's Animal and Plant Health Agency where she studied the effectiveness of TB vaccines in cattle and managed the roll-out of interferon-gamma-based diagnosis for bovine TB in the UK herd for the Department for Environment, Food and Rural Affairs. [5] While in this role, she co-published Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study with Susan Liebeschuetz. [6]
In 2008, Ewer became a Senior Immunologist at Oxford University's Edward Jenner Institute for Vaccine Research. [5] While there, she continued to study the effects of TB on populations and led clinical trials in an effort to discover a vaccine for Ebola. [7] The aim of her research was to define vaccine-induced immunological parameters that correlate with protection from malaria and understand why vaccines do not always work as well as expected. [8] During the COVID-19 pandemic, she led clinical controlled trials in an effort to find a vaccine, which was published in a 2020 study titled Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. [9]
Katie Ewer | |
---|---|
Academic background | |
Education | PhD, Immunology, 2004, Open University |
Thesis | Relationships between tuberculosis exposure, ex vivo antigen-specific T cell responses, and delayed type hypersensitivity in point-source outbreaks. (2004) |
Academic work | |
Institutions | University of Oxford |
Katie Jane Ewer is a British immunologist and Professor of Vaccine Immunology at the University of Oxford's Jenner Institute. [1]
When she did not get into medical school, Ewer pursued a career in biomedical science and became interested in infectious diseases. [2] She was interested in a career in biology for she was "fascinated by seemingly endless processes that occur in our cells and organs every second of our lives without us knowing about it. [3] Ewer earned an undergraduate degree in biomedical science, which included a year of microbiology training. [4] She then began working as a biomedical scientist at the microbiology department of the John Radcliffe Hospital in 2000, [5] before pursuing a PhD on the immunology of tuberculosis (TB). [4] Ewer earned her PhD at the Open University as a result of her research with Ajit Lalvani on novel diagnostic tools using T cells for the diagnosis of tuberculosis infection. [5]
Upon earning her PhD, Ewer joined the UK's Animal and Plant Health Agency where she studied the effectiveness of TB vaccines in cattle and managed the roll-out of interferon-gamma-based diagnosis for bovine TB in the UK herd for the Department for Environment, Food and Rural Affairs. [5] While in this role, she co-published Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study with Susan Liebeschuetz. [6]
In 2008, Ewer became a Senior Immunologist at Oxford University's Edward Jenner Institute for Vaccine Research. [5] While there, she continued to study the effects of TB on populations and led clinical trials in an effort to discover a vaccine for Ebola. [7] The aim of her research was to define vaccine-induced immunological parameters that correlate with protection from malaria and understand why vaccines do not always work as well as expected. [8] During the COVID-19 pandemic, she led clinical controlled trials in an effort to find a vaccine, which was published in a 2020 study titled Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. [9]